Overview
- 17 FDA inspections are on record.
- 6 inspections produced a Form 483.
- The most recent recorded inspection date is 2024-06-21.
At a glance
Inspections
17
Form 483s
6
EIRs
1
Last outcome
Clean
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 11 Jun 2024 – 21 Jun 2024 | Biologics | Clean | |
| 28 Feb 2022 – 9 Mar 2022 | Biologics | Clean | |
| 28 Feb 2022 | Biologics | Clean | |
| 25 Oct 2021 – 17 Nov 2021 | Medical Devices & Rad Health | 483 | View 483 → |
| 14 Nov 2017 – 18 Jan 2018 | Medical Devices & Rad Health | 483 | View 483 → |
| 5 Feb 2015 – 23 Feb 2015 | Biologics | Clean | |
| 17 Mar 2014 – 19 May 2014 | Biologics | 483 | View 483 → |
| 30 Nov 2012 | Not recorded | 483 | View 483 → |
| 9 Sep 2011 | Not recorded | Clean | |
| 30 Jul 2010 | Not recorded | 483 | View 483 → |
| 11 May 2010 | Not recorded | Clean | |
| 13 Mar 2009 | Not recorded | 483 | View 483 → |
Observations on record
Form 483 observations cited at this site, most recent first.
18 Jan 2018
21 CFR 1271.75(a)(1)
Risk factors, clinical evidence
Cited by Sarah M Forney, Jennifer L Custodio
18 Jan 2018
21 CFR 1271.75(a)(1)
Risk factors, clinical evidence
Cited by Sarah M Forney, Jennifer L Custodio
18 Jan 2018
21 CFR 1271.75(a)(1)
Risk factors, clinical evidence
Cited by Sarah M Forney, Jennifer L Custodio
19 May 2014
21 CFR 1271.160(b)(3)
Actions taken and documented
Cited by Sarah M Forney, Jennifer A Bazergui, Jennifer Macmillan
Investigators
FDA investigators tied to this site in the record.
Sarah M Forney10 insp.
Jennifer A Bazergui2 insp.
Jennifer Macmillan2 insp.
Charles D Boison1 insp.
Michele Gottshall1 insp.
Christopher J Adams1 insp.
Emily A Walters1 insp.
Jacqueline S Warner1 insp.
Jennifer L Custodio1 insp.
Juanita P Versace1 insp.
Eufemia G Gonzalez1 insp.
Lisa Mathew1 insp.
Susan T Hadman1 insp.
Dawn L Wydner1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 1271.320(c) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 1271.75(a)(1) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 1271.150(c)(1)(iii) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 1271.160(b)(5) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 1271.180(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 1271.195(a)(3) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 1271.195(c) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 1271.220(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 1271.250(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 1271.260(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 1271.350(a)(1) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 1271.160(b)(1) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.160(b)(3) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.160(b)(4) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.190(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.190(d)(1) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.200(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.200(e) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.210(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.220(c) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.225 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.230(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.230(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.260(d) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.265(c)(2) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.265(e) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.270(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.320(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.320(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.350(a)(2) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.350(b)(2) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.50(b)(1) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 803.50(a)(1) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 820.100(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 820.70(a)(2) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Musculoskeletal Transplant Foundation, Inc.'s 6 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat